Estimation and Inference for the Additive Mean Residual Life Model With Change Point in the Continuous Covariate.
1/5 보강
The mean residual life model offers comprehensive insights into the relationship between a patient's remaining life expectancy and various covariates.
APA
Lin Y, Yang X, Bai F (2025). Estimation and Inference for the Additive Mean Residual Life Model With Change Point in the Continuous Covariate.. Statistics in medicine, 44(10-12), e70133. https://doi.org/10.1002/sim.70133
MLA
Lin Y, et al.. "Estimation and Inference for the Additive Mean Residual Life Model With Change Point in the Continuous Covariate.." Statistics in medicine, vol. 44, no. 10-12, 2025, pp. e70133.
PMID
40405480
Abstract
The mean residual life model offers comprehensive insights into the relationship between a patient's remaining life expectancy and various covariates. In cancer research, a patient's lifespan may dramatically change when a covariate exceeds a threshold. Accurately detecting and estimating this change-point is crucial for predicting the patient's life expectancy and preventing diseases. To address these challenges, we investigate the additive mean residual life model with an unknown change-point in the continuous covariate. The martingale-based smoothed estimating equations are used to estimate the baseline mean residual life function, regression parameters, and the unknown change-point. Furthermore, we establish the large sample properties of the estimator under mild conditions, and propose a maximal Wald test statistic to test the existence of the change-point. Finally, we assess the finite sample performance of our proposed method through extensive simulation studies and apply it to two real data examples from studies on stomach cancer and primary biliary cirrhosis. Supplementary materials for this article are available online.
MeSH Terms
Humans; Computer Simulation; Models, Statistical; Stomach Neoplasms; Liver Cirrhosis, Biliary; Life Expectancy; Survival Analysis
같은 제1저자의 인용 많은 논문 (5)
- Postoperative Health-related Quality of Life in Reduction Mammaplasty: A Systematic Review and Meta-Analysis.
- Three-Year Follow-Up of Neoadjuvant Tislelizumab with Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: Revealing Cancer-Associated Fibroblast Heterogeneity Corresponding to PD-1 Blockade Efficacy.
- An XGBoost-Based Multicenter Model for Predicting HBV-Related Hepatocellular Carcinoma: Development and Validation.
- Development of a lactate metabolism signature for predicting homologous recombination repair status in breast cancer.
- Barriers and facilitators to population participation in colorectal cancer screening: an umbrella review.